According to Kymera Therapeutics's latest financial reports the company's current EPS (TTM) is -2,74ย โฌ. In 2022 the company made an earnings per share (EPS) of -2,75ย โฌ a decrease over its 2021 EPS that were of -1,97ย โฌ.